Synthetic control arms in clinical trials: Making it happen
Posted:
Can combining #AI tech & #RWD hold the key to overcoming challenges in #clinicaltrial design?
Join Sensyne Health on 24th February 2:00 p.m. GMT as experts discuss the application of #SyntheticControlArms – a new way of approaching clinical trials.
Generative AI voice agents—conversational systems powered by large language models that can understand and produce natural speech in real time—are poised to transform how health systems engage with patients.
Read more here.
Stanford Medicine researchers developed a way to create the first heart and liver organoids that generate their own blood vessels, possibly paving the way for organoid-based regenerative therapies.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us